EMEA warning: only use drug if other antifungals are not appropiate 2 ... as a reflection of the rising numbers of immunocompromised patients and the increasing use of aggressive immunosuppressive ...
Another issue is that antifungal drug development takes a long time and is very expensive. Fungal and human cells are more similar than bacterial and human cells, making finding antifungal targets ...
A drug used to combat fungal infections in cancer patients comes with a big caveat — research shows the medicine can last twice as long in people with obesity. This means chemotherapies may be ...
A 58-year-old male patient from Tripura was successfully treated for critical illnesses including septic shock and multi-organ dysfunction syndrome after 32 days at Father Muller Medical College ...